Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Emily Annika Burger


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Burger EA, Laprise JF, Sy S, Regan MC, Prem K, Jit M, Brisson M, Kim JJ. Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting. Int J Cancer. 2022 Nov 15; 151(10):1804-1809. PMID: 35512109.
    Citations:    Fields:    
  2. Hertzberg SN, Moe MC, Jørstad ØK, Petrovski BÉ, Burger E, Petrovski G. Healthcare expenditure of intravitreal anti-vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema. Acta Ophthalmol. 2022 Apr 25. PMID: 35467793.
    Citations:    Fields:    
  3. Portnoy A, Pedersen K, Nygård M, Trogstad L, Kim JJ, Burger EA. Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis. Med Decis Making. 2022 08; 42(6):795-807. PMID: 35255741.
    Citations:    Fields:    Translation:HumansPHPublic Health
  4. Portnoy A, Nygård M, Trogstad L, Kim JJ, Burger EA. Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in Norway. MDM Policy Pract. 2022 Jan-Jun; 7(1):23814683211071093. PMID: 35024449; PMCID: PMC8744166.
  5. Spencer JC, Campos NG, Burger EA, Sy S, Kim JJ. Potential effectiveness of a therapeutic HPV intervention campaign in Uganda. Int J Cancer. 2022 03 01; 150(5):847-855. PMID: 34741526; PMCID: PMC8732308.
    Citations:    Fields:    Translation:HumansPHPublic Health
  6. Pedersen K, Portnoy A, Sy S, Hansen BT, Tropé A, Kim JJ, Burger EA. Switching clinic-based cervical cancer screening programs to human papillomavirus self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women. Int J Cancer. 2022 02 01; 150(3):491-501. PMID: 34664271.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  7. Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA. Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation. Prev Med. 2021 09; 150:106688. PMID: 34303489.
    Citations:    Fields:    Translation:Humans
  8. Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ. Retraction: Impact and Cost-effectiveness of Human Papillomavirus Vaccination Campaigns. Cancer Epidemiol Biomarkers Prev. 2021 Jun; 30(6):1283. PMID: 34074734.
    Citations:    Fields:    
  9. Smith MA, Burger EA, Castanon A, de Kok IMCM, Hanley SJB, Rebolj M, Hall MT, Jansen EEL, Killen J, O'Farrell X, Kim JJ, Canfell K. Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis. Prev Med. 2021 10; 151:106623. PMID: 34029578; PMCID: PMC9433770.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  10. Castanon A, Rebolj M, Burger EA, de Kok IMCM, Smith MA, Hanley SJB, Carozzi FM, Peacock S, O'Mahony JF. Cervical screening during the COVID-19 pandemic: optimising recovery strategies. Lancet Public Health. 2021 07; 6(7):e522-e527. PMID: 33939965; PMCID: PMC8087290.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  11. Burger EA, Jansen EE, Killen J, Kok IM, Smith MA, Sy S, Dunnewind N, G Campos N, Haas JS, Kobrin S, Kamineni A, Canfell K, Kim JJ. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. J Med Screen. 2021 06; 28(2):213-216. PMID: 33730899; PMCID: PMC8484743.
    Citations: 4     Fields:    Translation:HumansCells
  12. Kim JJ, Simms KT, Killen J, Smith MA, Burger EA, Sy S, Regan C, Canfell K. Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS Med. 2021 03; 18(3):e1003534. PMID: 33705382; PMCID: PMC7951902.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  13. Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA. Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis. Prev Med. 2021 03; 144:106276. PMID: 33678239.
    Citations: 1     Fields:    Translation:Humans
  14. Fogelberg S, Clements MS, Pedersen K, Sy S, Sparén P, Kim JJ, Burger EA. Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden. PLoS One. 2020; 15(9):e0239611. PMID: 32997696; PMCID: PMC7526933.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  15. Burger EA, de Kok IMCM, Groene E, Killen J, Canfell K, Kulasingam S, Kuntz KM, Matthijsse S, Regan C, Simms KT, Smith MA, Sy S, Alarid-Escudero F, Vaidyanathan V, van Ballegooijen M, Kim JJ. Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. J Natl Cancer Inst. 2020 09 01; 112(9):955-963. PMID: 31821501.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  16. Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. Int J Cancer. 2021 02 15; 148(4):932-940. PMID: 32706907.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  17. Simms KT, Yuill S, Killen J, Smith MA, Kulasingam S, de Kok IMCM, van Ballegooijen M, Burger EA, Regan C, Kim JJ, Canfell K. Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecol Oncol. 2020 09; 158(3):710-718. PMID: 32723676.
    Citations: 5     Fields:    Translation:Humans
  18. de Kok IMCM, Burger EA, Naber SK, Canfell K, Killen J, Simms K, Kulasingam S, Groene E, Sy S, Kim JJ, van Ballegooijen M. The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology. Med Decis Making. 2020 05; 40(4):474-482. PMID: 32486894.
    Citations:    Fields:    Translation:Humans
  19. Kristiansen IS, Burger EA, Blasio BF. Covid-19: Simulation models for epidemics. Tidsskr Nor Laegeforen. 2020 04 21; 140(6). PMID: 32321234.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  20. Burger EA, Smith MA, Killen J, Sy S, Simms KT, Canfell K, Kim JJ. Projected time to elimination of cervical cancer in the USA: a comparative modelling study. Lancet Public Health. 2020 04; 5(4):e213-e222. PMID: 32057315.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  21. Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, Sy S, Regan C, Keane A, Caruana M, Nguyen DTN, Smith MA, Laprise JF, Jit M, Alary M, Bray F, Fidarova E, Elsheikh F, Bloem PJN, Broutet N, Hutubessy R. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020 02 22; 395(10224):575-590. PMID: 32007141; PMCID: PMC7043009.
    Citations: 110     Fields:    Translation:HumansPHPublic Health
  22. Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, Sy S, Regan C, Drolet M, Gingras G, Laprise JF, Torode J, Smith MA, Fidarova E, Trapani D, Bray F, Ilbawi A, Broutet N, Hutubessy R. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020 02 22; 395(10224):591-603. PMID: 32007142; PMCID: PMC7043006.
    Citations: 97     Fields:    Translation:HumansPHPublic Health
  23. Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ. Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):22-30. PMID: 31666282.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  24. Rodin D, Burger EA, Atun R, Barton M, Gospodarowicz M, Grover S, Hanna TP, Jaffray DA, Knaul FM, Lievens Y, Zubizarreta E, Milosevic M. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact. Lancet Oncol. 2019 07; 20(7):915-923. PMID: 31151906; PMCID: PMC7055962.
    Citations: 9     Fields:    Translation:Humans
  25. Hylin H, Thrane H, Pedersen K, Kristiansen IS, Burger EA. The healthcare costs of treating human papillomavirus-related cancers in Norway. BMC Cancer. 2019 May 07; 19(1):426. PMID: 31064346; PMCID: PMC6505196.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  26. Castle PE, Xie X, Xue X, Poitras NE, Lorey TS, Kinney WK, Wentzensen N, Strickler HD, Burger EA, Schiffman M. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Prev Med. 2019 01; 118:44-50. PMID: 30316878.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  27. Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ. Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):10-19. PMID: 29757775; PMCID: PMC6092220.
    Citations:    Fields:    Translation:HumansCells
  28. Kim JJ, Burger EA, Regan C, Sy S. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force. JAMA. 2018 08 21; 320(7):706-714. PMID: 30140882; PMCID: PMC8653579.
    Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
  29. Burger EA, Campos NG, Sy S, Regan C, Kim JJ. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine. 2018 08 06; 36(32 Pt A):4823-4829. PMID: 29807710.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  30. Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ. Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Prev Med. 2018 06; 111:177-179. PMID: 29548787.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  31. Pedersen K, Fogelberg S, Thamsborg LH, Clements M, Nygård M, Kristiansen IS, Lynge E, Sparén P, Kim JJ, Burger EA. An overview of cervical cancer epidemiology and prevention in Scandinavia. Acta Obstet Gynecol Scand. 2018 Jul; 97(7):795-807. PMID: 29388202.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  32. Pedersen K, Burger EA, Nygård M, Kristiansen IS, Kim JJ. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines. Eur J Cancer. 2018 03; 91:68-75. PMID: 29335156; PMCID: PMC5803338.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  33. Pedersen K, Burger EA, Campbell S, Nygård M, Aas E, Lönnberg S. Advancing the evaluation of cervical cancer screening: development and application of a longitudinal adherence metric. Eur J Public Health. 2017 12 01; 27(6):1089-1094. PMID: 29186461.
    Citations: 4     Fields:    Translation:Humans
  34. Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164. PMID: 29150480; PMCID: PMC5809257.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  35. Burger EA, Kim JJ, Sy S, Castle PE. Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer. Clin Infect Dis. 2017 Sep 15; 65(6):893-899. PMID: 28531261; PMCID: PMC5850533.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  36. Burger EA, Pedersen K, Sy S, Kristiansen IS, Kim JJ. Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway. Br J Cancer. 2017 Sep 05; 117(6):783-790. PMID: 28772279; PMCID: PMC5589995.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  37. Rodin D, Caulley L, Burger E, Kim J, Johnson-Obaseki S, Palma D, Louie AV, Hansen A, O'Sullivan B. Cost-Effectiveness Analysis of Radiation Therapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):709-717. PMID: 28244405.
    Citations: 6     Fields:    Translation:Humans
  38. Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. J Natl Cancer Inst. 2017 02; 109(2). PMID: 27754955; PMCID: PMC5068562.
    Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
  39. Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health. 2016 11; 1(1):e8-e17. PMID: 29253379; PMCID: PMC6727207.
    Citations: 80     Fields:    Translation:HumansPHPublic Health
  40. Burger EA, Sy S, Nygård M, Kim JJ. The Cost-Effectiveness of Cervical Self-Sampling to Improve Routine Cervical Cancer Screening: The Importance of Respondent Screening History and Compliance. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):95-103. PMID: 27624639; PMCID: PMC5225039.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  41. Pedersen K, Burger EA, Sy S, Kristiansen IS, Kim JJ. Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing. Gynecol Oncol. 2016 Nov; 143(2):326-333. PMID: 27542966; PMCID: PMC5077685.
    Citations: 6     Fields:    Translation:HumansCells
  42. Castle PE, Burger EA. Age of human papillomavirus vaccination? Lancet Infect Dis. 2016 10; 16(10):1091-1093. PMID: 27373899.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  43. Burger EA, Lee K, Saraiya M, Thompson TD, Chesson HW, Markowitz LE, Kim JJ. Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines. Cancer. 2016 07 01; 122(13):2057-66. PMID: 27124396; PMCID: PMC4911256.
    Citations: 18     Fields:    Translation:Humans
  44. Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Ann Intern Med. 2015 Oct 20; 163(8):589-97. PMID: 26414147; PMCID: PMC5104349.
    Citations: 32     Fields:    Translation:HumansPHPublic Health
  45. Pedersen K, Sørbye SW, Burger EA, Lönnberg S, Kristiansen IS. Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program. Value Health. 2015 Dec; 18(8):1088-97. PMID: 26686795.
    Citations: 4     Fields:    Translation:Humans
  46. Hansen BT, Campbell S, Burger E, Nygård M. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents. Prev Med. 2015 Aug; 77:4-10. PMID: 25944266.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
  47. Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol. 2014 Sep 01; 180(5):545-55. PMID: 25081182.
    Citations: 48     Fields:    Translation:HumansCells
  48. Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway. J Infect Dis. 2015 Jan 15; 211(2):206-15. PMID: 25057044; PMCID: PMC4342693.
    Citations: 8     Fields:    Translation:Humans
  49. Burger EA, Nygård M, Gyrd-Hansen D, Moger TA, Kristiansen IS. Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women. BMC Public Health. 2014 Apr 15; 14:360. PMID: 24735469.
    Citations: 8     Fields:    Translation:HumansCells
  50. Burger EA, Kim JJ. The value of improving failures within a cervical cancer screening program: an example from Norway. Int J Cancer. 2014 Oct 15; 135(8):1931-9. PMID: 24615416.
    Citations: 6     Fields:    Translation:Humans
  51. Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys. PLoS One. 2014; 9(3):e89974. PMID: 24651645.
    Citations: 33     Fields:    Translation:HumansCellsPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Burger's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (144)
Co-Authors (8)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.